U.S. Biological Buffers Market was Valued at USD 0.38 Billion in 2025 and is Expected to Reach USD 0.70 billion by 2033 Due to Rising Biologics and Vaccine DevelopmentAustin, Jan. 20, 2026 (GLOBE ...
Anteris Technologies Global Corp. (“Anteris” or the “Company”) (NASDAQ: AVR, ASX: AVR), a global structural heart company committed to designing, developing, and commercializing cutting-edge medical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results